Bicara Therapeutics Inc
Bicara Therapeutics Inc (BCAX) Option Chain
Read more
Tracking the BCAX option chain helps you see every strike and expiry on Bicara Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BCAX options activity at a glance. Use our scanner to monitor the BCAX option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BCAX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where BCAX options are being actively traded, and where they are not.
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.51 | 0 | 0 | -0.20 | 6.15 | 3.90 | 8.00 | 2.50 | -69.47 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 99.49 |
| 17.18 | 0 | 0 | -0.20 | 3.65 | 1.40 | 5.50 | 5.00 | -38.95 | — | 0.15 | 0.00 | 0.15 | 24 | 0 | 82.82 |
| 50.13 | 0 | 0 | 3.75 | 1.15 | — | 4.90 | 7.50 | -8.42 | 0.15 | 0.55 | 0.00 | 0.35 | 100 | 432 | 49.87 |
| 75.10 | 50 | 8 | 0.45 | 0.00 | — | 0.45 | 10.00 | +22.10 | — | 4.90 | 1.35 | 3.55 | 0 | 0 | 24.90 |
| 88.50 | 1,385 | 0 | 0.20 | 0.00 | — | 0.20 | 12.50 | +52.63 | 2.00 | 6.40 | 3.85 | 0.35 | 0 | 4 | 11.50 |
As of Nov 5, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank96.83% High
- Market cap (M$)542
- 52 weeks high-73.57%
- 52 weeks low4.07%
- Analyst recommendationStrong Buy
1.31 - Target price$33.18
283.58% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-3.09
- EPS growth next 5 years-10.86%
As of Nov 5, 2026